Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 9

Results: 14

The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38<sup>SAPK</sup> pathway.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1135, doi. 10.1038/onc.2012.135

By:

Hennigan, R F;
Moon, C A;
Parysek, L M;
Monk, K R;
Morfini, G;
Berth, S;
Brady, S;
Ratner, N

Publication type:

Article

Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1193, doi. 10.1038/onc.2012.120

By:

Chen, P-L;
Chen, C-F;
Chen, Y;
Guo, X E;
Huang, C-K;
Shew, J-Y;
Reddick, R L;
Wallace, D C;
Lee, W-H

Publication type:

Article

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1173, doi. 10.1038/onc.2012.128

By:

Ward, A;
Balwierz, A;
Zhang, J D;
Küblbeck, M;
Pawitan, Y;
Hielscher, T;
Wiemann, S;
Sahin, Ö

Publication type:

Article

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1155, doi. 10.1038/onc.2012.132

By:

Yin, D;
Ogawa, S;
Kawamata, N;
Leiter, A;
Ham, M;
Li, D;
Doan, N B;
Said, J W;
Black, K L;
Phillip Koeffler, H

Publication type:

Article

Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1082, doi. 10.1038/onc.2012.134

By:

Sher, Y-P;
Chang, C-M;
Juo, C-G;
Chen, C-T;
Hsu, J L;
Lin, C-Y;
Han, Z;
Shiah, S-G;
Hung, M-C

Publication type:

Article

Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1183, doi. 10.1038/onc.2012.126

By:

Zheng, H X;
Cai, Y D;
Wang, Y D;
Cui, X B;
Xie, T T;
Li, W J;
Peng, L;
Zhang, Y;
Wang, Z Q;
Wang, J;
Jiang, B

Publication type:

Article

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1099, doi. 10.1038/onc.2012.137

By:

Weiler, M;
Pfenning, P-N;
Thiepold, A-L;
Blaes, J;
Jestaedt, L;
Gronych, J;
Dittmann, L M;
Berger, B;
Jugold, M;
Kosch, M;
Combs, S E;
von Deimling, A;
Weller, M;
Bendszus, M;
Platten, M;
Wick, W

Publication type:

Article

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1073, doi. 10.1038/onc.2012.158

By:

Kufe, D W

Publication type:

Article

Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1091, doi. 10.1038/onc.2012.118

By:

Sarek, G;
Ma, L;
Enbäck, J;
Järviluoma, A;
Moreau, P;
Haas, J;
Gessain, A;
Koskinen, P J;
Laakkonen, P;
Ojala, P M

Publication type:

Article

Rage signalling promotes intestinal tumourigenesis.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1202, doi. 10.1038/onc.2012.119

By:

Heijmans, J;
Büller, N V J A;
Hoff, E;
Dihal, A A;
van der Poll, T;
van Zoelen, M A D;
Bierhaus, A;
Biemond, I;
Hardwick, J C H;
Hommes, D W;
Muncan, V;
van den Brink, G R

Publication type:

Article

Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1110, doi. 10.1038/onc.2012.139

By:

Wei, S;
Chen, X;
McGraw, K;
Zhang, L;
Komrokji, R;
Clark, J;
Caceres, G;
Billingsley, D;
Sokol, L;
Lancet, J;
Fortenbery, N;
Zhou, J;
Eksioglu, E A;
Sallman, D;
Wang, H;
Epling-Burnette, P K;
Djeu, J;
Sekeres, M;
Maciejewski, J P;
List, A

Publication type:

Article

The miR-99 family regulates the DNA damage response through its target SNF2H.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1164, doi. 10.1038/onc.2012.131

By:

Mueller, A C;
Sun, D;
Dutta, A

Publication type:

Article

Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1121, doi. 10.1038/onc.2012.136

By:

Pullamsetti, S S;
Banat, G A;
Schmall, A;
Szibor, M;
Pomagruk, D;
Hänze, J;
Kolosionek, E;
Wilhelm, J;
Braun, T;
Grimminger, F;
Seeger, W;
Schermuly, R T;
Savai, R

Publication type:

Article

Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity.

Published in:

Oncogene, 2013, v. 32, n. 9, p. 1144, doi. 10.1038/onc.2012.133

By:

Lee, P-C;
Lee, H-J;
Kakadiya, R;
Sanjiv, K;
Su, T-L;
Lee, T-C

Publication type:

Article